Optimised Osmolality in Oral Supplements Optimised Osmolality in Oral Supplements

NCT ID: NCT07231666

Last Updated: 2025-11-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

14 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-11-11

Study Completion Date

2022-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Quasi-randomized, crossover intervention study, testing osmolality in oral drinks and effect on 6-hours ileostomy output in adult patients with an ileostomy

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

14 patients with ileostomies were included in a quasi-randomized, crossover intervention study. Each patient ingested between 3-18 different supplements during separate 6-hours intervention periods. Ileostomy output and urine volume will be collected. Outcome measures include faecal wet-weight, urine volume, electrolytes, osmolality, and body composition measured with bioelectrical impedance analysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ileostomy - Stoma Intestinal Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

This was a single-centre, quasi-randomised cross-over intervention study. The effects of osmolality in oral supplements were investigated using a 3x3 cross-over design.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants
The patients were randomised to receive either the hypo-osmolar or hyper-osmolar in their first intervention. Microsoft Excel feature "RAND" (Microsoft version 16) was used to randomize oral supplements. Each supplement was assigned a number. Every time a patient agreed to one or two more intervention periods, two supplements were randomized. One of the primary investigators (JQ) enrolled and randomized supplements to the patients

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

hypoosmolar

One with a hypo-osmolar fluid

Group Type ACTIVE_COMPARATOR

water

Intervention Type DIETARY_SUPPLEMENT

oral commercially available supplements

isoosmolar

one with an iso-osmolar fluid

Group Type ACTIVE_COMPARATOR

semi skimmed milk or powerade

Intervention Type DIETARY_SUPPLEMENT

oral commercially available supplements

hyperosmolar

one with a hyper-osmolar

Group Type ACTIVE_COMPARATOR

juice

Intervention Type DIETARY_SUPPLEMENT

oral commercially available supplements

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

water

oral commercially available supplements

Intervention Type DIETARY_SUPPLEMENT

semi skimmed milk or powerade

oral commercially available supplements

Intervention Type DIETARY_SUPPLEMENT

juice

oral commercially available supplements

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. age 18 years or higher
2. ileostomy formed at least 8 weeks before enrolment
3. consent to participate

Exclusion Criteria

1. pregnancy
2. known chronic kidney disease
3. known diabetes mellitus
4. too long driving distance
5. parenteral nutrition/fluid more than 6 litres per month
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of medicine V (Hepatology and Gastroenterology)

Aarhus C, , Denmark

Site Status

Aarhus University Hospital

Aarhus N, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Quist JR, Rud CL, Frumer K, Julsgaard M, Dahl Baunwall SM, Hvas CL. Osmolality in oral supplements drives ileostomy output: Defining the Goldilocks zone. Clin Nutr ESPEN. 2024 Jun;61:88-93. doi: 10.1016/j.clnesp.2024.03.003. Epub 2024 Mar 15.

Reference Type RESULT
PMID: 38777478 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-10-72-289-21

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Postoperative Oral Intake Trial
NCT00134407 COMPLETED PHASE1